Accueil > Actualité
Actualite financiere : Actualite bourse

Novartis : Q2 core EPS up 1%

( - Novartis has reported Q2 core EPS of 1.
56 dollar, up 1% at constant exchange rates (+10% excluding the impact of Roche's core earnings), and core operating income of 4.27 billion dollars, up 5% at constant exchante rates.

The Swiss healthcare group's sales rose 5% at constant exchange rates to nearly 12.8 billion dollars, with strong performance from key growth brands including Entresto, Kesimpta, Cosentyx, Kisqali and Zolgensma.

Novartis has confirmed its guidance for 2022, while upgrading its Sandoz division, expecting low-single digit sales growth and core operating income broadly in line with its level in 2021.

Copyright (c) 2022 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.